MRPL1
gene geneOn this page
Also known as BM022uL1m
Summary
MRPL1 (mitochondrial ribosomal protein L1, HGNC:14275) is a protein-coding gene on chromosome 4q21.1, encoding Large ribosomal subunit protein uL1m (Q9BYD6). It is a selective cancer dependency (DepMap: 11.4% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein that belongs to the L1 ribosomal protein family.
Source: NCBI Gene 65008 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 57 total
- Cancer dependency (DepMap): dependent in 11.4% of screened cell lines
- MANE Select transcript:
NM_020236
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14275 |
| Approved symbol | MRPL1 |
| Name | mitochondrial ribosomal protein L1 |
| Location | 4q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | BM022, uL1m |
| Ensembl gene | ENSG00000169288 |
| Ensembl biotype | protein_coding |
| OMIM | 611821 |
| Entrez | 65008 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 7 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000315567, ENST00000502384, ENST00000504901, ENST00000506674, ENST00000511521, ENST00000515625, ENST00000865377, ENST00000865378, ENST00000865379, ENST00000915229, ENST00000915230
RefSeq mRNA: 1 — MANE Select: NM_020236
NM_020236
CCDS: CCDS3583
Canonical transcript exons
ENST00000315567 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001140502 | 77949797 | 77949878 |
| ENSE00001140507 | 77909266 | 77909372 |
| ENSE00001522312 | 77952489 | 77952785 |
| ENSE00001522345 | 77862830 | 77862879 |
| ENSE00003497142 | 77883242 | 77883500 |
| ENSE00003548653 | 77885256 | 77885339 |
| ENSE00003586620 | 77894139 | 77894250 |
| ENSE00003652051 | 77887220 | 77887291 |
| ENSE00003679813 | 77871744 | 77871855 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 95.74.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 23.7090 / max 531.8351, expressed in 1790 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 48429 | 19.9612 | 1781 |
| 48428 | 2.9582 | 1287 |
| 48427 | 0.7897 | 490 |
Top tissues by expression
258 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 95.74 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.42 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.96 | gold quality |
| deltoid | UBERON:0001476 | 94.74 | gold quality |
| biceps brachii | UBERON:0001507 | 94.69 | gold quality |
| quadriceps femoris | UBERON:0001377 | 94.32 | gold quality |
| vastus lateralis | UBERON:0001379 | 94.21 | gold quality |
| tibialis anterior | UBERON:0001385 | 94.19 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 93.78 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.71 | gold quality |
| adrenal tissue | UBERON:0018303 | 93.69 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.63 | gold quality |
| muscle tissue | UBERON:0002385 | 93.43 | gold quality |
| myocardium | UBERON:0002349 | 93.25 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 93.23 | gold quality |
| muscle of leg | UBERON:0001383 | 92.99 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 92.94 | gold quality |
| rectum | UBERON:0001052 | 92.93 | gold quality |
| gastrocnemius | UBERON:0001388 | 92.88 | gold quality |
| embryo | UBERON:0000922 | 92.85 | gold quality |
| ganglionic eminence | UBERON:0004023 | 92.85 | gold quality |
| heart left ventricle | UBERON:0002084 | 92.59 | gold quality |
| cardiac ventricle | UBERON:0002082 | 92.49 | gold quality |
| cortical plate | UBERON:0005343 | 92.30 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.95 | gold quality |
| heart right ventricle | UBERON:0002080 | 91.81 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 91.78 | silver quality |
| ventricular zone | UBERON:0003053 | 91.49 | gold quality |
| heart | UBERON:0000948 | 91.46 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 90.85 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.62 |
| E-CURD-112 | no | 3.72 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting MRPL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-3913-3P | 99.74 | 66.53 | 938 |
| HSA-MIR-4465 | 99.71 | 72.56 | 2096 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-103A-1-5P | 99.39 | 67.78 | 1545 |
| HSA-MIR-103A-2-5P | 99.39 | 67.72 | 1577 |
| HSA-MIR-302A-5P | 99.39 | 68.21 | 1913 |
| HSA-MIR-4999-5P | 99.35 | 69.15 | 926 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
| HSA-MIR-943 | 97.81 | 64.42 | 694 |
| HSA-MIR-526B-5P | 97.41 | 67.99 | 1074 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 11.4% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- MLRP1 could possibly serve as a candidate gene for alterations associated with asbestos exposure. (PMID:26463840)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrpl1 | ENSDARG00000054606 |
| mus_musculus | Mrpl1 | ENSMUSG00000029486 |
| rattus_norvegicus | Mrpl1 | ENSRNOG00000002070 |
Protein
Protein identifiers
Large ribosomal subunit protein uL1m — Q9BYD6 (reviewed: Q9BYD6)
Alternative names: 39S ribosomal protein L1, mitochondrial
All UniProt accessions (2): Q9BYD6, H0Y8N7
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the universal ribosomal protein uL1 family.
RefSeq proteins (1): NP_064621* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005879 | Ribosomal_uL1_mit | Family |
| IPR016095 | Ribosomal_uL1_3-a/b-sand | Homologous_superfamily |
| IPR023674 | Ribosomal_uL1-like | Homologous_superfamily |
| IPR028364 | Ribosomal_uL1/biogenesis | Family |
Pfam: PF00687
UniProt features (7 total): sequence conflict 3, sequence variant 2, transit peptide 1, chain 1
Structure
Experimental structures (PDB)
18 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 9PR4 | ELECTRON MICROSCOPY | 2.77 |
| 9PRA | ELECTRON MICROSCOPY | 2.83 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8OIT | ELECTRON MICROSCOPY | 2.9 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 9PGI | ELECTRON MICROSCOPY | 3.02 |
| 9PG8 | ELECTRON MICROSCOPY | 3.06 |
| 9PS7 | ELECTRON MICROSCOPY | 3.08 |
| 8OIR | ELECTRON MICROSCOPY | 3.1 |
| 9PSI | ELECTRON MICROSCOPY | 3.12 |
| 9PGM | ELECTRON MICROSCOPY | 3.18 |
| 9PS0 | ELECTRON MICROSCOPY | 3.29 |
| 7A5K | ELECTRON MICROSCOPY | 3.7 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYD6-F1 | 78.90 | 0.56 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 137 (showing top):
GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, YY1_02, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, PPAR_DR1_Q2, GARY_CD5_TARGETS_DN, AACTTT_UNKNOWN, MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN, chr4q21, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GOCC_LARGE_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOME
GO Biological Process (2): mitochondrial translation (GO:0032543), translation (GO:0006412)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial large ribosomal subunit (GO:0005762), ribosome (GO:0005840), large ribosomal subunit (GO:0015934), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar large ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| ribosomal subunit | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
3254 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPL1 | MRPL36 | Q9P0J6 | 646 |
| MRPL1 | MRPL46 | Q9H2W6 | 618 |
| MRPL1 | MRPL2 | Q5T653 | 593 |
| MRPL1 | MRPL4 | Q9BYD3 | 567 |
| MRPL1 | MRPL24 | Q96A35 | 564 |
| MRPL1 | MRPL11 | Q9Y3B7 | 559 |
| MRPL1 | MRPL52 | Q86TS9 | 557 |
| MRPL1 | MRPS18A | Q9NVS2 | 557 |
| MRPL1 | MRPL12 | P52815 | 549 |
| MRPL1 | MRPL13 | Q9BYD1 | 547 |
| MRPL1 | MRPL54 | Q6P161 | 547 |
| MRPL1 | MRPS18C | Q9Y3D5 | 543 |
| MRPL1 | MRPL40 | Q9NQ50 | 538 |
| MRPL1 | MRPL20 | Q9BYC9 | 536 |
| MRPL1 | MRPL39 | Q9NYK5 | 534 |
| MRPL1 | MRPL19 | P49406 | 534 |
IntAct
170 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NDUFAF1 | NDUFS3 | psi-mi:“MI:0914”(association) | 0.790 |
| YBX1 | HNRNPR | psi-mi:“MI:0914”(association) | 0.770 |
| MRPS30 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.640 |
| IGF2BP1 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| COQ5 | COQ9 | psi-mi:“MI:0914”(association) | 0.590 |
| MRPL1 | GOPC | psi-mi:“MI:0915”(physical association) | 0.560 |
| VPS52 | MRPL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPAG16 | MRPL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPD | HNRNPDL | psi-mi:“MI:0914”(association) | 0.560 |
| NP | KPNA6 | psi-mi:“MI:0914”(association) | 0.550 |
| MRPL50 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| CIRBP | PRMT5 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL10 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL42 | GATC | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL28 | MRPL3 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL41 | MRPL3 | psi-mi:“MI:0914”(association) | 0.530 |
| YBX1 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| HNRNPA1 | PTCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| IGF2BP3 | PTCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL13 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL18 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (259): MRPL1 (Two-hybrid), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), MRPL1 (Affinity Capture-MS), ATP6V1H (Co-fractionation), CORO1B (Co-fractionation), MRPL1 (Co-fractionation), MRPL1 (Co-fractionation)
ESM2 similar proteins: A5D7S3, A5PKL6, A6NHR9, A6NNW6, A6QPQ5, A6QPR9, A8K855, O02789, O75717, P27641, P59328, P60670, P82933, Q0IHV1, Q2T9V5, Q32KZ1, Q496Z9, Q4R6C7, Q4R6Y8, Q58DQ5, Q5F204, Q5M882, Q5R5T0, Q5R952, Q5RL51, Q5TZF3, Q69ZX6, Q6AZN0, Q6DDT5, Q6P5D8, Q7Z2T5, Q8CE96, Q8NEC7, Q8R3N6, Q8TAT6, Q8VDY4, Q8VI84, Q8WTT2, Q91Y26, Q96FV9
Diamond homologs: A6QPQ5, Q2S1Q2, Q99N96, Q9BYD6, Q7UI03
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPL1 | “form complex” | “39S mitochondrial large ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 141 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial ribosome-associated quality control | 31 | 35.9× | 1e-38 |
| Mitochondrial translation | 27 | 35.0× | 1e-33 |
| Mitochondrial translation initiation | 29 | 34.7× | 6e-36 |
| Mitochondrial translation elongation | 29 | 34.7× | 6e-36 |
| Mitochondrial translation termination | 29 | 30.0× | 6e-34 |
| Translation | 29 | 17.0× | 3e-26 |
| Peptide chain elongation | 9 | 10.8× | 7e-06 |
| Viral mRNA Translation | 9 | 10.8× | 7e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 31 | 42.4× | 3e-40 |
| positive regulation of cytoplasmic translation | 5 | 39.0× | 1e-05 |
| translation | 25 | 20.2× | 2e-23 |
| negative regulation of translation | 9 | 13.9× | 3e-06 |
| cytoplasmic translation | 9 | 13.1× | 3e-06 |
| regulation of alternative mRNA splicing, via spliceosome | 6 | 11.5× | 9e-04 |
| mRNA transport | 5 | 10.4× | 6e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 38 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1355 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:77871727:AT:A | acceptor_gain | 1.0000 |
| 4:77871728:T:G | acceptor_gain | 1.0000 |
| 4:77871741:A:AG | acceptor_gain | 1.0000 |
| 4:77871742:A:G | acceptor_gain | 1.0000 |
| 4:77871743:G:GA | acceptor_gain | 1.0000 |
| 4:77871743:GCC:G | acceptor_gain | 1.0000 |
| 4:77871743:GCCT:G | acceptor_gain | 1.0000 |
| 4:77871743:GCCTT:G | acceptor_gain | 1.0000 |
| 4:77871851:ACAAA:A | donor_gain | 1.0000 |
| 4:77871852:CAAA:C | donor_gain | 1.0000 |
| 4:77871853:AAA:A | donor_gain | 1.0000 |
| 4:77871853:AAAG:A | donor_loss | 1.0000 |
| 4:77871854:AA:A | donor_gain | 1.0000 |
| 4:77871855:AG:A | donor_loss | 1.0000 |
| 4:77871856:G:GG | donor_gain | 1.0000 |
| 4:77871857:TAAG:T | donor_loss | 1.0000 |
| 4:77883240:A:G | acceptor_gain | 1.0000 |
| 4:77883348:G:GT | donor_gain | 1.0000 |
| 4:77885247:T:G | acceptor_gain | 1.0000 |
| 4:77887214:T:TA | acceptor_gain | 1.0000 |
| 4:77887217:TA:T | acceptor_loss | 1.0000 |
| 4:77887218:A:AG | acceptor_gain | 1.0000 |
| 4:77887218:AGA:A | acceptor_loss | 1.0000 |
| 4:77887219:G:GG | acceptor_gain | 1.0000 |
| 4:77887219:GA:G | acceptor_gain | 1.0000 |
| 4:77887219:GAAT:G | acceptor_gain | 1.0000 |
| 4:77887288:GAAG:G | donor_gain | 1.0000 |
| 4:77894130:A:AG | acceptor_gain | 1.0000 |
| 4:77894134:TTCAG:T | acceptor_loss | 1.0000 |
| 4:77894135:TCAG:T | acceptor_loss | 1.0000 |
AlphaMissense
2157 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:77952518:A:C | S297R | 0.993 |
| 4:77952520:T:A | S297R | 0.993 |
| 4:77952520:T:G | S297R | 0.993 |
| 4:77949831:T:C | L271P | 0.989 |
| 4:77894175:G:C | A199P | 0.986 |
| 4:77952527:A:C | S300R | 0.984 |
| 4:77952529:T:A | S300R | 0.984 |
| 4:77952529:T:G | S300R | 0.984 |
| 4:77885329:T:A | V159E | 0.983 |
| 4:77883415:T:C | L106P | 0.982 |
| 4:77909368:C:A | A258E | 0.982 |
| 4:77909367:G:C | A258P | 0.981 |
| 4:77952516:G:C | R296P | 0.979 |
| 4:77883460:T:A | V121D | 0.978 |
| 4:77885332:T:C | F160S | 0.978 |
| 4:77883355:T:A | V86D | 0.974 |
| 4:77952498:T:A | V290E | 0.974 |
| 4:77952507:C:A | A293D | 0.974 |
| 4:77883402:G:C | A102P | 0.973 |
| 4:77887242:C:A | A170E | 0.973 |
| 4:77885323:T:A | V157D | 0.972 |
| 4:77909365:T:A | I257K | 0.972 |
| 4:77949829:T:A | N270K | 0.970 |
| 4:77949829:T:G | N270K | 0.970 |
| 4:77894173:T:A | V198E | 0.968 |
| 4:77894176:C:A | A199D | 0.968 |
| 4:77883478:T:C | L127P | 0.967 |
| 4:77952504:G:C | R292P | 0.967 |
| 4:77952513:T:C | L295P | 0.965 |
| 4:77952513:T:G | L295R | 0.965 |
dbSNP variants (sampled 300 via entrez): RS1000020507 (4:77950361 A>G), RS1000032632 (4:77920518 G>A), RS1000046904 (4:77895739 T>A), RS1000088843 (4:77895493 G>C), RS1000119969 (4:77895860 T>G), RS1000173479 (4:77923342 C>T), RS1000200455 (4:77902921 A>G), RS1000236852 (4:77928810 TTTA>T), RS1000306621 (4:77910383 G>A,C), RS1000381357 (4:77881842 G>A), RS1000392181 (4:77888067 C>T), RS1000476212 (4:77888382 G>A,T), RS1000480944 (4:77942561 A>C,G), RS1000483787 (4:77909371 C>G,T), RS1000491044 (4:77943831 C>G)
Disease associations
OMIM: gene MIM:611821 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003542_16 | Night sleep phenotypes | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
47 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| FR900359 | increases phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| 2,3,5-(triglutathion-S-yl)hydroquinone | increases ADP-ribosylation | 1 |
| cylindrospermopsin | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| pinostrobin | increases phosphorylation | 1 |
| ICG 001 | affects expression | 1 |
| jinfukang | decreases expression | 1 |
| NSC 689534 | decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Curcumin | increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.